Liaoning Cheng Da Co., Ltd. (SHA:600739)
China · Delayed Price · Currency is CNY 10.88
-0.05 (-0.46%)
Jul 31, 2026, 3:00 PM CST
Liaoning Cheng Da Financials Overview
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Revenue Revenue Growth | 9,432 | 9,902 | 10,770 | 10,783 | 14,565 | 18,373 |
Revenue Growth | -12.43% | -8.06% | -0.12% | -25.97% | -20.73% | 8.43% |
Gross Profit Gross Profit Growth | 679.69 | 715.64 | 1,481 | 1,289 | 2,596 | 2,537 |
Operating Income Operating Income Growth | -754.5 | -713.01 | 58.84 | -50.82 | 1,202 | 1,192 |
Net Income Net Income Growth | 940.13 | 736.55 | 209.56 | 233.08 | 1,224 | 2,159 |
Earnings Per Share EPS Growth | 0.62 | 0.48 | 0.14 | 0.15 | 0.80 | 1.41 |
EPS Growth | 100.40% | 251.34% | -10.00% | -80.90% | -43.26% | -22.08% |
| Fiscal Year | FY 2025 |
|---|---|
| Period Ending | Dec '25 Dec 31, 2025 |
Stock Headquarters Stock Headquarters Growth | 9.02 |
Domestic and Foreign Trade Domestic and Foreign Trade Growth | 8,493 |
Biopharmaceutical Biopharmaceutical Growth | 1,390 |
Offset Of Business Segment Offset Of Business Segment Growth | -3.6 |
Energy Development Energy Development Growth | 3.23 |
Total Total Growth | 9,892 |
| Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Cash & Investments Cash & Investments Growth | 8,308 | 8,054 | 7,045 | 7,089 | 9,060 | 9,198 |
Total Debt Total Debt Growth | 15,809 | 15,081 | 14,259 | 13,979 | 14,419 | 14,768 |
Net Cash (Debt) Net Cash Growth | -7,502 | -7,027 | -7,214 | -6,890 | -5,359 | -5,570 |
Net Cash Growth | - | - | - | - | - | - |
Net Cash Per Share Net Cash Per Share Growth | -4.93 | -4.62 | -4.74 | -4.52 | -3.51 | -3.64 |
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Operating Cash Flow Operating Cash Flow Growth | 440.17 | 337.64 | 610.24 | 119.71 | 1,427 | 313.81 |
Capital Expenditures CapEx Growth | -308.58 | -340.87 | -455.36 | -703.05 | -647.04 | -613.53 |
Free Cash Flow Free Cash Flow Growth | 131.59 | -3.24 | 154.88 | -583.34 | 780.3 | -299.71 |
Free Cash Flow Growth | -48.58% | - | - | - | - | - |
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Gross Margin | 7.21% | 7.23% | 13.75% | 11.95% | 17.83% | 13.81% |
Operating Margin | -8.00% | -7.20% | 0.55% | -0.47% | 8.25% | 6.49% |
Pretax Margin | 5.92% | 4.07% | 6.87% | 1.01% | 11.78% | 14.34% |
Profit Margin | 9.97% | 7.44% | 1.95% | 2.16% | 8.40% | 11.75% |
FCF Margin | 1.40% | -0.03% | 1.44% | -5.41% | 5.36% | -1.63% |
| Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Aug '26 Aug 1, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Dividend Per Share Dividend Per Share Growth | 0.150 | 0.150 | 0.020 | 0.100 | 0.150 | 0.220 |
Dividend Per Share Growth | -80.00% | 650.00% | -80.00% | -33.43% | -31.72% | 0% |
Dividend Yield | 1.38% | 1.34% | 0.19% | 0.86% | 1.22% | 1.17% |
| Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Aug '26 Aug 1, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
PE Ratio | 17.62 | 23.11 | 75.19 | 76.94 | 15.69 | 13.83 |
Forward PE | - | 21.48 | 21.48 | 21.48 | 21.48 | 21.48 |
P/FCF Ratio | 125.87 | - | 101.73 | - | 24.60 | - |
PS Ratio | 1.76 | 1.72 | 1.46 | 1.66 | 1.32 | 1.63 |